Logo image of DCFC

TRITIUM DCFC LTD (DCFC) Stock Fundamental Analysis

USA - NASDAQ:DCFC - AU0000325136 - Common Stock

3.64 USD
+0.05 (+1.39%)
Last: 4/17/2024, 8:00:01 PM
1.35 USD
-2.29 (-62.91%)
Pre-Market: 4/19/2024, 8:49:24 AM
Fundamental Rating

2

Taking everything into account, DCFC scores 2 out of 10 in our fundamental rating. DCFC was compared to 92 industry peers in the Electrical Equipment industry. DCFC may be in some trouble as it scores bad on both profitability and health. DCFC shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DCFC had negative earnings in the past year.
DCFC had a negative operating cash flow in the past year.
DCFC Yearly Net Income VS EBIT VS OCF VS FCFDCFC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

The Return On Assets of DCFC (-44.11%) is worse than 78.82% of its industry peers.
Industry RankSector Rank
ROA -44.11%
ROE N/A
ROIC N/A
ROA(3y)-58.9%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCFC Yearly ROA, ROE, ROICDCFC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 200 -200 400 600 800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DCFC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DCFC Yearly Profit, Operating, Gross MarginsDCFC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

DCFC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCFC has more shares outstanding
DCFC has a worse debt/assets ratio than last year.
DCFC Yearly Shares OutstandingDCFC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M
DCFC Yearly Total Debt VS Total AssetsDCFC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

DCFC has an Altman-Z score of -2.71. This is a bad value and indicates that DCFC is not financially healthy and even has some risk of bankruptcy.
DCFC has a Altman-Z score of -2.71. This is amonst the worse of the industry: DCFC underperforms 81.18% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.71
ROIC/WACCN/A
WACC4.2%
DCFC Yearly LT Debt VS Equity VS FCFDCFC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M

2.3 Liquidity

A Current Ratio of 0.92 indicates that DCFC may have some problems paying its short term obligations.
DCFC's Current ratio of 0.92 is on the low side compared to the rest of the industry. DCFC is outperformed by 91.76% of its industry peers.
A Quick Ratio of 0.37 indicates that DCFC may have some problems paying its short term obligations.
DCFC's Quick ratio of 0.37 is on the low side compared to the rest of the industry. DCFC is outperformed by 95.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.37
DCFC Yearly Current Assets VS Current LiabilitesDCFC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

7

3. Growth

3.1 Past

DCFC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.77%, which is quite impressive.
The Revenue has grown by 115.03% in the past year. This is a very strong growth!
Measured over the past years, DCFC shows a very strong growth in Revenue. The Revenue has been growing by 57.75% on average per year.
EPS 1Y (TTM)22.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.61%
Revenue 1Y (TTM)115.03%
Revenue growth 3Y57.75%
Revenue growth 5YN/A
Sales Q2Q%288.54%

3.2 Future

DCFC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.99% yearly.
The Revenue is expected to grow by 49.26% on average over the next years. This is a very strong growth
EPS Next Y99.69%
EPS Next 2Y41.45%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year152.01%
Revenue Next 2Y121.82%
Revenue Next 3Y47.11%
Revenue Next 5Y49.26%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DCFC Yearly Revenue VS EstimatesDCFC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
DCFC Yearly EPS VS EstimatesDCFC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DCFC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DCFC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCFC Price Earnings VS Forward Price EarningsDCFC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DCFC Per share dataDCFC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 200 -200

4.3 Compensation for Growth

A more expensive valuation may be justified as DCFC's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.45%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

DCFC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRITIUM DCFC LTD

NASDAQ:DCFC (4/17/2024, 8:00:01 PM)

Premarket: 1.35 -2.29 (-62.91%)

3.64

+0.05 (+1.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-07 2024-03-07/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.09M
Analysts80
Price Target1264.8 (34647.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20117.5%
PT rev (3m)25467%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)26.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.78
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-200.52
FCFYN/A
OCF(TTM)-191.09
OCFYN/A
SpS217.06
BVpS-168.94
TBVpS-168.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.9%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 329.63%
Cap/Sales 4.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.37
Altman-Z -2.71
F-Score2
WACC4.2%
ROIC/WACCN/A
Cap/Depr(3y)253.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.7%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.61%
EPS Next Y99.69%
EPS Next 2Y41.45%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)115.03%
Revenue growth 3Y57.75%
Revenue growth 5YN/A
Sales Q2Q%288.54%
Revenue Next Year152.01%
Revenue Next 2Y121.82%
Revenue Next 3Y47.11%
Revenue Next 5Y49.26%
EBIT growth 1Y-9.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.18%
EBIT Next 3Y34.44%
EBIT Next 5YN/A
FCF growth 1Y-81.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-87.05%
OCF growth 3YN/A
OCF growth 5YN/A